Page 33 - Collaborative Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Agriculture Economic Development Grant Program -United States 105SHARES Applications are now open for “ Agriculture Economic Development” grant program that will assist local farmers to develop new sources of agricultural income through the provision of cost-share grants. Applicants must be able to demonstrate that their operation is a verifiable farm business. The farm tract and farming operation on which the funds are to be used must be in Orange County. The maximum amount any one farm can receive within 3 years of initial funding is $10,000. Multiple applications and subsequent awards ...

TAGRISSO Approved in the US for the Adjuvant Treatment of Patients With Early-Stage EGFR-mutated Lung Cancer Approval based on unprecedented results from the ADAURA Phase III trial where TAGRISSO WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s TAGRISSO ® (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumor resection with curative intent. TAGRISSO is indicated for EGFRm patients whose tumors have exon 19 deletions or exon 21 L858R mutations as ...

ADDING MULTIMEDIA TAGRISSO Approved in the US for the Adjuvant Treatment of Patients With Early-Stage EGFR-mutated Lung Cancer Approval based on unprecedented results from the ADAURA Phase III trial where TAGRISSO WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s TAGRISSO ® (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumor resection with curative intent. TAGRISSO is indicated for EGFRm patients whose tumors have exon 19 deletions or exon 21 L...

AstraZeneca’s Tagrisso (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after tumour resection with curative intent. Tagrisso is indicated for EGFRm patients whose tumours have exon 19 deletions or exon 21 L858R mutations as detected by an approved test. The approval was granted under the US Food and Drug Administration’s (FDA) Real-Time Oncology Review (RTOR) pilot program. Five other countries participated in a concurrent submission and review proc...

Dec 11, 2020 But study used non-standard PEEP ventilation strategy A ventilation strategy with lower positive end-expiratory pressure (PEEP) held its own against a higher-PEEP strategy in patients without acute respiratory distress syndrome (ARDS) according to researchers in the Netherlands, although Canadian experts pointed out that neither strategy was in line with standard care. In the non-inferiority trial performed at eight ICUs, “patients randomized to the lower PEEP strategy had a median of 18 ventilator-free days while patients randomized to the higher PEEP strategy had a median of ...